Published in Brain Res on September 14, 2007
Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol (2010) 2.56
Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs (2010) 1.67
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics (2009) 1.36
Multifunctional drugs for head injury. Neurotherapeutics (2009) 1.16
Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med (2009) 1.14
Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit. Brain Res (2009) 1.09
Neuroprotective strategies for traumatic brain injury: improving clinical translation. Int J Mol Sci (2014) 1.04
Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma (2010) 1.03
Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system. Brain Res (2008) 1.01
Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target (2010) 0.99
Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor. Transl Stroke Res (2011) 0.92
Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. J Neuroinflammation (2013) 0.92
Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina (2010) 0.89
Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury. Mediators Inflamm (2012) 0.88
Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria. Malar J (2009) 0.87
Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease. Adv Biomed Res (2012) 0.86
Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury. Brain Res (2011) 0.84
Impact of statins on cognitive deficits in adult male rodents after traumatic brain injury: a systematic review. Biomed Res Int (2014) 0.83
Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury. J Neurotrauma (2014) 0.80
Improved cerebrovascular function and reduced histological damage with darbepoietin alfa administration after cortical impact injury in rats. J Pharmacol Exp Ther (2011) 0.80
Investigation of the protective effect of erythropoietin on spinal cord injury in rats. Exp Ther Med (2011) 0.77
Erythropoietin in the neurology ICU. Curr Treat Options Neurol (2013) 0.76
Endothelial nitric oxide synthase mediates the cerebrovascular effects of erythropoietin in traumatic brain injury. Front Immunol (2014) 0.75
Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way? F1000Res (2016) 0.75
Erythropoietin for the treatment of subarachnoid hemorrhage: A feasible ingredient for a successful medical recipe. Mol Med (2015) 0.75
Effects of Quercetin and Mannitol on Erythropoietin Levels in Rats Following Acute Severe Traumatic Brain Injury. J Korean Neurosurg Soc (2017) 0.75
Dose-dependent neuroprotective effect of enoxaparin on cold-induced traumatic brain injury. Neural Regen Res (2017) 0.75
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression. J Nephrol (2016) 0.75
Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science (2004) 4.09
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A (2004) 3.40
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol (2009) 3.01
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis (2008) 2.85
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol (2002) 2.46
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? Radiology (2013) 2.12
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res (2008) 1.90
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A (2003) 1.88
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol (2007) 1.83
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett (2009) 1.68
Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant (2007) 1.65
Femoro-distal bypass with varicose veins covered by prosthetic mesh. J Surg Res (2011) 1.47
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? Acta Obstet Gynecol Scand (2002) 1.46
Propofol relieves post-extubation laryngospasm in obstetric anesthesia. Int J Obstet Anesth (2004) 1.41
The many faces of erythropoietin: from erythropoiesis to a rational neuroprotective strategy. Expert Opin Investig Drugs (2008) 1.41
Down subjects and Oriental population share several specific attitudes and characteristics. Med Hypotheses (2007) 1.39
Vascular endothelial growth factor induces brain erythropoietin expression? Funct Neurol (2006) 1.38
Smaller molecular-sized anaesthetics oligomerize Abeta peptide simulating Alzheimer's disease: a relevant issue. Eur J Anaesthesiol (2009) 1.38
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res (2009) 1.31
Anaesthetic-related neuroprotection: intravenous or inhalational agents? CNS Drugs (2010) 1.23
Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A (2002) 1.22
Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery (2005) 1.18
Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist (2004) 1.18
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function. Kidney Blood Press Res (2008) 1.12
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res (2009) 1.09
Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg Spine (2006) 1.09
Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis. J Alzheimers Dis (2010) 0.96
Isoflurane and desflurane at clinically relevant concentrations induce amyloid beta-peptide oligomerization: an NMR study. Biochem Biophys Res Commun (2008) 0.95
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. Acta Obstet Gynecol Scand (2008) 0.95
NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma (2007) 0.94
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. Nephrology (Carlton) (2010) 0.93
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? Med Sci Monit (2010) 0.93
Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol (2002) 0.91
Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage. Neurosurgery (2009) 0.91
Erythropoietin: not just about erythropoiesis. Lancet (2010) 0.90
The treatment of large supratentorial arachnoid cysts in infants with cyst-peritoneal shunting and Hakim programmable valve. Childs Nerv Syst (2003) 0.89
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. Acta Diabetol (2013) 0.89
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth. Eur J Cancer (2007) 0.89
New insights on the role of vitamin D in the progression of renal damage. Kidney Blood Press Res (2013) 0.88
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients. Nephrol Dial Transplant (2009) 0.88
In clinical practice, coadministration of sevoflurane or propofol could antagonize remifentanil stimulation of N-methyl-D-aspartate receptors. Anesthesiology (2005) 0.87
Drugs of anaesthesia and cancer. Surg Oncol (2009) 0.87
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. J Investig Med (2010) 0.87
Assessment of human brain water content by cerebral bioelectrical impedance analysis: a new technique and its application to cerebral pathological conditions. Neurosurgery (2002) 0.87
Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein. Med Res Rev (2013) 0.87
The role of erythropoietin in neuroprotection: therapeutic perspectives. Drug News Perspect (2007) 0.86
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study. Eur J Pharmacol (2008) 0.85
Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS (2004) 0.85
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study. Ther Apher Dial (2010) 0.85
Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? J Neurosurg (2002) 0.85
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. J Nephrol (2009) 0.84
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. Oncol Rep (2010) 0.84
Management of patients after renal graft loss: an open question for nephrologists. Ren Fail (2006) 0.83
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. J Reprod Med (2007) 0.83
Aneurysm clipping following endovascular coil embolization: a report of two cases. Med Sci Monit (2009) 0.83
Malnutrition in the elderly patient on dialysis. Ren Fail (2009) 0.82
Possible role of erythropoietin in the pathogenesis of chronic cor pulmonale. Nephrol Dial Transplant (2005) 0.82
CD68 and CR3/43 immunohistochemical expression in secretory meningiomas. Neurosurgery (2005) 0.82
Thyroid function, Alzheimer's disease and postoperative cognitive dysfunction: a tale of dangerous liaisons? J Alzheimers Dis (2008) 0.82
Methylenetetrahydrofolate reductase mutation in subjects with abdominal aortic aneurysm subdivided for age. Clin Hemorheol Microcirc (2006) 0.82
Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. BJOG (2004) 0.82
Obestatin: an interesting but controversial gut hormone. Ann Nutr Metab (2011) 0.82
Hydrocarbons and kidney damage: potential use of neutrophil gelatinase-associated lipocalin and sister chromatide exchange. Am J Nephrol (2012) 0.82
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. Kidney Blood Press Res (2010) 0.81
Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Crit Care Med (2008) 0.81
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. Eur J Pharmacol (2006) 0.81
Caffeine and the kidney: what evidence right now? J Ren Nutr (2007) 0.81
Unusual recurrence of trigeminal neuralgia after microvascular decompression by muscle interposal. Med Sci Monit (2011) 0.81
Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause (2005) 0.81
Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function. J Investig Med (2008) 0.81
Erythropoietin and its lost receptor. Nephrol Dial Transplant (2007) 0.81
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation. Clin Exp Med (2014) 0.81
NGAL is a precocious marker of therapeutic response. Curr Pharm Des (2011) 0.81
Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology (2006) 0.80
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. Shock (2009) 0.80
Transcranial Doppler ultrasonography in the assessment of cerebral circulation arrest: improving sensitivity by transcervical and transorbital carotid insonation and serial examinations. Neurocrit Care (2009) 0.80
Prevalence of SENV-H and SENV-D virus: epidemiological study in blood donors and dialysis patients. Ren Fail (2006) 0.80
Coadministration of propofol and midazolam decreases bispectral index value as a result of synergic muscle relaxant action on the motor system. Anesthesiology (2004) 0.80
The inhibition of central nicotinic nAch receptors is the possible cause of prolonged cognitive impairment after anesthesia. Anesth Analg (2003) 0.80
Inhaled anesthesia and cognitive performance. Drugs Today (Barc) (2009) 0.79
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. Kidney Blood Press Res (2011) 0.79
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. J Surg Res (2008) 0.79
Effects of haemodialysis on circulating endothelial progenitor cell count. Blood Purif (2007) 0.79
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. Ren Fail (2012) 0.79
Both IL-1β and TNF-α regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients. Mediators Inflamm (2011) 0.79
Apelin, plasmatic osmolality and hypotension in dialyzed patients. Blood Purif (2012) 0.79
Subclavian stenosis/occlusion in patients with subclavian steal and previous bypass of internal mammary interventricular anterior artery: medical or surgical treatment? Ann Vasc Surg (2004) 0.79